01.08.2019 Issue 433

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Webinar to Spotlight HEOR, RWE
Sourcing Strategies, Practices

Monday, January 7

An upcoming Jan. 24 webinar, titled "HEOR & RWE: Global Sourcing Strategies and Best Practices," will spotlight ways global research organizations can better navigate the key hurdles involved in developing RWE and HEOR strategies for demonstrating product value.

HealthEconomics.Com’s Online Career Fair Nears

Take Our Survey on High-Quality Value Communication

House Dems Defend Health Care Law

Major BCBS Plan Implements Inovalon Data Solutions

FDA Mulls Expanded Use of RWE to Measure Effectiveness

Trump Keeps Pressure on Pharma as it Hikes Prices


Senior Research Analyst - HEOR

Principal - Health Technology Assessments

Lead Health Economist

Researcher - HEOR

Industry Spotlight


Conferences Webinars
Reimbursement and Contracting
    January 23-24, Philadelphia, Pennsylvania

Data Analytics and Decisions
    January 23-24, Philadelphia, Pennsylvania

Special Therapies 2019
    January 24-25, Las Vegas, Nevada

The Payer and Provider Ecosystem Evolution
    January 27-30, San Diego, California

Identifying Medical Conditions in Administrative Claims Data: Validation and Machine Learning
    January 8

How to Leverage Real World Data to Achieve Faster Insights for Better Adverse Event Detection and Reporting
    January 16

AI and the Augmented Age in Health Care
    January 23


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions


 
Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven
Share this newsletter on social media:

Email Twitter Facebook LinkedIn